This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Brain Cancer, Neoplasm Metastasis, Cancer of Brain and Nervous System or Metastatic Malignant Neoplasm to Brain
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

The maximum tolerated dose of 3-session (ie, treatment) stereotactic radiosurgery to treat brain metastases greater than 4.2 cm3 in size will be determined. This study investigates if increasing radiation dose improves outcome for patients without greater toxicity (side effects).

Provided treatments

  • Radiation: Fractionated Stereotactic Radiosurgery
  • Procedure: Surgical resection of the tumor
Tris trial is registered with FDA with number: NCT00928226. The sponsor of the trial is Stanford University and it is looking for 120 volunteers for the current phase.
Official trial title:
A Phase I/II Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases